Publication | Open Access

Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour

Tumor BiologyOncologyHigh SensitivityMedicineTheranosticsPathologyPharmacotherapyAnti-cancer AgentCancer TreatmentPotential EffectivenessPharmacologyTumor MicroenvironmentCancer Research